Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1634 1683 1699
This examiner grants 30% of resolved cases
Art Unit 1634 in Tech Center 1600 is where BAUSCH, SARAE L manages patent applications. With 611 resolved cases, the examiner maintains an allowance rate of 29.8%. The median days to allowance is 1388. These data points help practitioners set expectations for prosecution duration and outcomes.
The interview lift is 44.7%. This figure represents the difference in outcomes for cases with an interview compared to the 29.8% baseline. The 44.7% lift and the 611 resolved cases are factors in developing a strategy for this examiner.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18289332 | AUTOANTIBODIES FOR USE IN IDENTIFYING DISEASE | Non-Final OA | The Johns Hopkins University |
| 17995246 | NOVEL INSECTICIDAL TOXIN RECEPTORS AND METHODS OF USE | Final Rejection | PIONEER HI-BRED INTERNATIONAL, INC. |
| 18026823 | METHOD FOR DETERMINING A VIRALLY-INFECTED SUBJECT'S RISK OF DEVELOPING SEVERE SYMPTOMS | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18005515 | Systems and Methods to Enhance RNA Transcription and Uses Thereof | Final Rejection | The Board of Trustees of the Leland Stanford Junior University |
| 18685199 | Nucleotide Sequence Identification Method | Final Rejection | Hitachi High-Tech Corporation |
| 18252185 | METHOD FOR PREDICTING RESPONSIVENESS TO PLK1 INHIBITION | Non-Final OA | National University of Singapore |
| 18065307 | IDENTIFICATION AND TREATMENT OF OPIOID USE DISORDER | Non-Final OA | BATTELLE MEMORIAL INSTITUTE |
| 18006590 | RAPID CLINICAL TEST FOR GENETIC DIAGNOSIS INVOLVING KNOWN VARIANTS | Non-Final OA | YALE UNIVERSITY |
| 18266404 | COMPOSITIONS AND METHODS FOR DETECTING AND TREATING ORAL CAVITY SQUAMOUS CELL CARCINOMA | Final Rejection | THE UNIVERSITY OF CHICAGO |
| 18570745 | CRISPR CASCADE | Non-Final OA | The Board of Trustees of the University of Illinois |
| 17928170 | Compositions and Methods for Detecting Respiratory Viruses Including Coronaviruses | Non-Final OA | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA |
| 18565767 | METHODS FOR PREDICTING AND TREATING CHEMORESISTANCE IN SMALL CELL LUNG CANCER PATIENTS | Non-Final OA | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH |
| 17920931 | METHODS FOR DETECTING TISSUE DAMAGE, GRAFT VERSUS HOST DISEASE, AND INFECTIONS USING CELL-FREE DNA PROFILING | Final Rejection | CORNELL UNIVERSITY |
| 17611805 | METHODS FOR PREDICTING RESPONSIVENESS OF CANCER TO FERROPTOSIS-INDUCING THERAPIES | Final Rejection | Memorial Sloan Kettering Cancer Center |
| 17611536 | OLIGONUCLEOTIDE, OMICS ANALYSIS METHOD, AND OMICS ANALYSIS KIT | Non-Final OA | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy